Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope‐specific B‐, T‐helper and T‐killer cell response
- 1 September 1992
- journal article
- review article
- Published by Wiley in International Journal of Peptide and Protein Research
- Vol. 40 (3-4) , 255-260
- https://doi.org/10.1111/j.1399-3011.1992.tb00299.x
Abstract
Lymphocyte subpopulations involved in the self and nonself recognition processes are antibody producing cells, T-helper cells and T-killer cells. By using lipopeptide adjuvants and lipopeptide-antigen conjugates each of the major pathways of immune response can be specifically addressed on the molecular level of minimized synthetic lipopeptide vaccines. The immunologically active principle of the lipopeptide constructs is the synthetic N-terminus of bacterial lipoprotein, tri-palmitoyl-S-glycerylcysteine, which can be covalently linked to B-, T-helper and CTL epitopes. Methods of multiple peptide synthesis based on Merrifield's solid-phase synthesis allow the economic production of the high numbers of overlapping lipopeptides required for the complete immunological screening of viral proteins.Keywords
This publication has 42 references indexed in Scilit:
- Covalent lipoprotein from the outer membrane of escherichia coliPublished by Elsevier ,2003
- Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathwayImmunology Today, 1991
- Synthesis of Nα‐Fmoc protected derivatives of S‐(2,3‐dihydroxypropyl)‐cysteine and their application in peptide synthesisInternational Journal of Peptide and Protein Research, 1991
- Histopathological studies on the local reactions induced by complete fReund's adjuvant (CFA), bacterial lipopolysaccharide (LPS), and synthetic lipopeptide (P3C) conjugatesThe Journal of Pathology, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991
- Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cellsNature, 1990
- Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb moleculeNature, 1990
- Enhancement of Protection against Salmonella Infection in Mice Mediated by a Synthetic Lipopeptide Analogue of Bacterial Lipoprotein in S. typhimurium VaccinesZentralblatt für Bakteriologie, 1989
- Lipopeptide Derivatives of Bacterial Lipoprotein Constitute Potent Immune Adjuvants Combined with or Covalently Coupled to Antigen or HaptenBiological Chemistry Hoppe-Seyler, 1989
- Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytesEuropean Journal of Biochemistry, 1987